皮膚病治療市場：按應用、藥物類別和地區分類

Dermatological Therapeutic Market, By Application, By Drug Class, By Geography

出版日期: 2026年05月14日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，皮膚病治療市場規模將達到 547.6 億美元，到 2033 年將達到 941 億美元。預計 2026 年至 2033 年的複合年成長率將達到 8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	547.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.00%	2033年市場規模預測：	941億美元

皮膚科是醫學的一個分支，專門研究皮膚疾病。皮膚病嚴重影響人們的生活品質。皮膚科治療方法擴大用於治療各種皮膚問題，包括色素沉著、皮膚再生、皮膚緊緻以及與老齡化相關的真皮和血管病變。與手術相比，皮膚科治療方法具有非侵入性、耗時更短、成本更低、療效更佳等優點。

市場動態

皮膚病負擔日益加重、老年人口不斷成長、對安全有效治療方法的需求不斷成長、意識提升、研發活動活性化以及新治療方法頻繁核准上市，預計這些因素將成為推動全球皮膚病治療市場成長的主要因素。

例如，2022年7月，Almirall宣布透過其開放式創新平台「AlmirallShare」啟動第七輪提案徵集，旨在建立皮膚病學研究領域的合作夥伴關係。其目標是尋找與臨床前或臨床開發相關的全新合作機會，這些合作有望最終開發出治療皮膚疾病的新治療方法。

此外，2021 年 2 月，百時美施貴寶公司宣布了兩項主要 III 期試驗的積極結果，這兩項試驗評估了口服選擇性蛋白酪氨酸激酶2 (TYK2) 抑制劑 deuclavatinib 對中重度斑塊型乾癬患者的療效。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本報告根據公司亮點、產品系列、主要特點、財務表現和策略等參數，介紹了全球皮膚病治療市場主要參與者的概況。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球皮膚病治療市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球皮膚病治療市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- LEO Pharma
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson
- GlaxoSmithKline PLC
- Galderma
- Amgen Inc.
- Almirall SA
- XBiotech USA Inc.
- AbbVie Inc.
- Bausch Health Companies Inc.

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI5490

Dermatological Therapeutic Market is estimated to be valued at USD 54,760 Mn in 2026 and is expected to reach USD 94,100 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 54,760 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.00%	2033 Value Projection:	USD 94,100 Mn

Dermatology is an area of medicine dealing specifically with the skin. Skin diseases have a serious impact on people's quality of life. Dermatology therapeutics are used to treat increasing cases of pigmented skin, skin resurfacing, skin tightening, and age-related dermal/vascular lesions, among others. Dermatology treatments are non-invasive require less time, cost-effective, and offer better results as compared to surgeries.

Market Dynamics

Rise in burden of dermatology diseases, growing geriatric population, rise in demand for safe and effective therapeutics, rise in awareness among people, increase in research and development, and frequent approvals and launches of novel therapeutics are major factors expected to drive growth of the global dermatological therapeutic market.

For instance, in July 2022, Almirall announced the launch of its 7th call through AlmirallShare, its open innovation platform, for proposals to establish collaborations in dermatological research. The aim of this is to find new partnership opportunities for assets in preclinical or clinical development stages that can become new treatments for skin diseases.

Moreover, in February 2021, Bristol Myers Squibb announced positive results from two pivotal Phase 3 trials evaluating deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of patients with moderate to severe plaque psoriasis.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global dermatological therapeutic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Leo Pharma, Pfizer Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline PLC, Galderma, Amgen Inc., Almirall, S.A., XBiotech USA Inc., AbbVie Inc, and Bausch Health Companies Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global dermatological therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatological therapeutic market.

Market Segmentation

By Application (Revenue, USD Mn, 2021-2033)
- Alopecia
- Herpes
- Psoriasis
- Rosacea
- Atopic Dermatitis
- Acne Vulgaris
- Vitiligo
- Hidradenitis
- Other Applications
By Drug Class (Revenue, USD Mn, 2021-2033)
- Anti-infectives
- Corticosteroids
- Calcineurin Inhibitors
- Retinoids
- Other Drug Classes
By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- LEO Pharma
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson
- GlaxoSmithKline PLC
- Galderma
- Amgen Inc.
- Almirall S.A.
- XBiotech USA Inc.
- AbbVie Inc.
- Bausch Health Companies Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Drug Class
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Dermatological Therapeutic Market, By Application, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Herpes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Psoriasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Atopic Dermatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Acne Vulgaris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Vitiligo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Hidradenitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Dermatological Therapeutic Market, By Drug Class, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Anti-infectives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Calcineurin Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Other Drug Classes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Dermatological Therapeutic Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- LEO Pharma
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- GlaxoSmithKline PLC
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Galderma
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Almirall S.A.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- XBiotech USA Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bausch Health Companies Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views